|
AKAP9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.375700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.661080E-03 |
| Normal-vs-Stage2 |
1.215730E-02 |
| Normal-vs-Stage3 |
1.605680E-04 |
| Normal-vs-Stage4 |
7.663600E-03 |
| Stage1-vs-Stage2 |
7.665000E-01 |
| Stage1-vs-Stage3 |
3.088000E-01 |
| Stage1-vs-Stage4 |
9.748600E-01 |
| Stage2-vs-Stage3 |
6.939200E-01 |
| Stage2-vs-Stage4 |
7.968000E-01 |
| Stage3-vs-Stage4 |
4.373400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.448700E-04 |
| Normal-vs-AfricanAmerican |
5.869200E-01 |
| Normal-vs-Asian |
5.624000E-03 |
| Caucasian-vs-AfricanAmerican |
7.132000E-02 |
| Caucasian-vs-Asian |
9.784400E-01 |
| AfricanAmerican-vs-Asian |
9.835500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.96779999999919E-05 |
| Normal-vs-Female |
1.819430E-03 |
| Male-vs-Female |
3.473200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.900200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.301650E-03 |
| Normal-vs-Age(61-80Yrs) |
4.357800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.185810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.942800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.312400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.095200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.126800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.614600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.335550E-01 |
| Classical-VS-Follicular |
3.393300E-04 |
| Classical-VS-Other |
3.720400E-01 |
| Classical-VS-Normal |
1.818040E-02 |
| Tall-VS-Follicular |
4.244200E-01 |
| Tall-VS-Other |
8.845600E-01 |
| Tall-VS-Normal |
1.702800E-03 |
| Follicular-VS-Other |
7.635600E-01 |
| Follicular-VS-Normal |
4.49420000003808E-06 |
| Other-VS-Normal |
5.734400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.77370000000221E-05 |
| Normal-vs-N1 |
3.641200E-04 |
| N0-vs-N1 |
6.717600E-01 |
|
|
